Pengyu Wang

Xianning, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Yubai Wan ameliorates vitiligo by inhibiting ferroptosis via NRF2/GPX4 pathway.

Yubai Wan ameliorates vitiligo by inhibiting ferroptosis via NRF2/GPX4 pathway.

Journal: Journal of ethnopharmacology

Published: September 20, 2025

Corrigendum to "BOLA3 as a key protein for the treatment of diabetic skeletal muscle atrophy" [Int. Immunopharmacol. 164 (2025) 115383].

Corrigendum to "BOLA3 as a key protein for the treatment of diabetic skeletal muscle atrophy" [Int. Immunopharmacol. 164 (2025) 115383].

Journal: International immunopharmacology

Published: September 04, 2025

Luteolin attenuates trimethyltin chloride-induced hippocampal neurotoxicity through SIRT3/NRF2/HO-1 activation.

Luteolin attenuates trimethyltin chloride-induced hippocampal neurotoxicity through SIRT3/NRF2/HO-1 activation.

Journal: Neuropharmacology

Published: February 26, 2025

BOLA3 as a key protein for the treatment of diabetic skeletal muscle atrophy.

BOLA3 as a key protein for the treatment of diabetic skeletal muscle atrophy.

Journal: International immunopharmacology

Published: February 04, 2025

The intricate interplay between dietary habits and cognitive function: insights from the gut-brain axis.

The intricate interplay between dietary habits and cognitive function: insights from the gut-brain axis.

Journal: Frontiers in nutrition

Published: December 04, 2024

NCAPD3-mediated ferroptosis of 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside inhibits proliferation in T47D cells.

NCAPD3-mediated ferroptosis of 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside inhibits proliferation in T47D cells.

Journal: Frontiers in pharmacology

Published: November 20, 2024

Bioinformatics analysis combined with experimental validation reveals the novel mechanisms of multi-targets of dapagliflozin attenuating diabetic liver injury.

Bioinformatics analysis combined with experimental validation reveals the novel mechanisms of multi-targets of dapagliflozin attenuating diabetic liver injury.

Journal: Frontiers in endocrinology

Published: October 29, 2024

Dapagliflozin attenuates skeletal muscle atrophy in diabetic nephropathy mice through suppressing Gasdermin D-mediated pyroptosis.

Dapagliflozin attenuates skeletal muscle atrophy in diabetic nephropathy mice through suppressing Gasdermin D-mediated pyroptosis.

Journal: International immunopharmacology

Published: August 17, 2024

Schisandrin A Attenuates Diabetic Nephropathy via EGFR/AKT/GSK3β Signaling Pathway Based on Network Pharmacology and Experimental Validation.

Schisandrin A Attenuates Diabetic Nephropathy via EGFR/AKT/GSK3β Signaling Pathway Based on Network Pharmacology and Experimental Validation.

Journal: Biology

Published: July 02, 2024

Apigenin inhibits proliferation and differentiation of cardiac fibroblasts through AKT/GSK3β signaling pathway.

Apigenin inhibits proliferation and differentiation of cardiac fibroblasts through AKT/GSK3β signaling pathway.

Journal: Journal of ethnopharmacology

Published: April 04, 2024

Showing 1-10 of 10

Last Updated: 09/26/2026